Interpace Diagnostics Announces Contract with Blue Cross Blue Shield of Michigan

Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it has contracted with Blue Cross Blue Shield (BCBS) of Michigan.  The contract makes the ThyGeNEXT® and ThyraMIR® tests both covered services as well as in-network services for their total of 6 million members.

Source: https://www.globenewswire.com/news-release/2019/07/31/1894566/0/en/Interpace-Diagnostics-Announces-Contract-with-Blue-Cross-Blue-Shield-of-Michigan.html